Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5656357 | HPB | 2017 | 10 Pages |
Abstract
IBT is associated with an increased risk of morbidity but does not impact on long-term outcomes. Need for IBT should be considered as a surrogate of advanced disease requiring complex resection. Still, restricted transfusion policy should remain advocated for IHCC resection.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Concepción Gómez-Gavara, Alexandre Doussot, Chetana Lim, Chady Salloum, Eylon Lahat, David Fuks, Olivier Farges, Jean Marc Regimbeau, Daniel Azoulay,